Published in Eur J Cancer on October 19, 2010
Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol (2015) 1.65
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis. Onco Targets Ther (2013) 1.44
Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J (2014) 1.16
RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis. Mol Ther (2011) 0.93
IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis. PLoS One (2015) 0.92
Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Oncotarget (2015) 0.87
CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain. Int J Mol Sci (2013) 0.87
Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis (2012) 0.86
Oral epithelial stem cells - implications in normal development and cancer metastasis. Exp Cell Res (2014) 0.84
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis. Mol Cancer (2013) 0.79
CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model. Clin Exp Metastasis (2014) 0.79
COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration. BMC Cancer (2014) 0.79
CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. Biomed Res Int (2014) 0.78
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer. Cancer Gene Ther (2015) 0.78
Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions. Mediators Inflamm (2012) 0.77
The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer. PLoS One (2013) 0.77
Involvement of miR-518c-5p to growth and metastasis in oral cancer. PLoS One (2014) 0.77
CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis. BMC Cancer (2016) 0.76
The lymphatic system and pancreatic cancer. Cancer Lett (2015) 0.76
Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. Diagn Pathol (2017) 0.75
Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma. Oncol Lett (2016) 0.75
Silencing Rab14 represses the proliferation and migration of oral squamous cell carcinoma, and enhances cisplatin sensitivity. Am J Transl Res (2017) 0.75
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol (2009) 2.05
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. J Nucl Med (2007) 1.75
Ocular adnexal mucosa-associated lymphoid tissue lymphoma with polyclonal hypergammaglobulinemia. Am J Ophthalmol (2008) 1.63
Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma. Int J Hematol (2010) 1.63
Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood (2002) 1.28
Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol (2006) 1.24
Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma. Lab Invest (2004) 1.09
CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol (2005) 1.08
The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol (2004) 1.03
Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol Cancer Res (2007) 1.01
Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Cancer Sci (2010) 1.00
Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol (2010) 0.98
Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells. Oral Oncol (2004) 0.97
Establishment and characterization of a spontaneously immortalized mouse ameloblast-lineage cell line. Biochem Biophys Res Commun (2003) 0.97
Hydrothermal modification of titanium surface in calcium solutions. Biomaterials (2002) 0.96
Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma. J Clin Exp Hematop (2007) 0.92
Fracture mechanisms of retrieved titanium screw thread in dental implant. Biomaterials (2002) 0.92
Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells. Mol Cancer (2009) 0.92
Epimorphin is involved in differentiation of rat hepatic stem-like cells through cell-cell contact. Biochem Biophys Res Commun (2003) 0.91
Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy. Br J Haematol (2002) 0.91
Fabrication of Zn containing apatite cement and its initial evaluation using human osteoblastic cells. Biomaterials (2002) 0.88
Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan. Int J Hematol (2012) 0.88
Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis (2012) 0.86
Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma. Int J Hematol (2006) 0.86
Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies. Leuk Res (2006) 0.86
Implant-supported edentulous maxillary obturators with milled bar attachments after maxillectomy. J Oral Maxillofac Surg (2004) 0.86
Effects of apatite cements on proliferation and differentiation of human osteoblasts in vitro. Biomaterials (2003) 0.85
PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation. Genes Chromosomes Cancer (2012) 0.85
Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa. J Oral Pathol Med (2003) 0.85
Effects of low crystalline carbonate apatite on proliferation and osteoblastic differentiation of human bone marrow cells. J Mater Sci Mater Med (2015) 0.85
Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition. Cancer Med (2014) 0.84
Aberrant DNA methylation of the p57KIP2 gene is a sensitive biomarker for detecting minimal residual disease in diffuse large B cell lymphoma. Leuk Res (2009) 0.83
Evaluation of 15 mandibular reconstructions with Dumbach Titan Mesh-System and particulate cancellous bone and marrow harvested from bilateral posterior ilia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.83
Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells. Int J Oncol (2013) 0.82
Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells. Int J Oncol (2004) 0.82
Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials (2012) 0.82
Basic research on aw-AC/PLGA composite scaffolds for bone tissue engineering. J Mater Sci Mater Med (2007) 0.81
Stable inhibition of NF-kappa B in salivary gland cells does not enhance sensitivity to TNF-alpha-induced apoptosis due to upregulation of TRAF-1 expression. Exp Cell Res (2002) 0.81
Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma. Int J Hematol (2013) 0.81
Effects of various sterilization methods on the setting and mechanical properties of apatite cement. J Biomed Mater Res B Appl Biomater (2004) 0.81
Influence of smoking on osseointegrated implant failure: a meta-analysis. Clin Oral Implants Res (2006) 0.80
Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies. Cancer Sci (2012) 0.80
A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection. J Cancer Res Clin Oncol (2015) 0.80
Evaluation of feasibility of hydroxyapatite putty as a local hemostatic agent for bone. J Biomed Mater Res (2002) 0.79
Osteoporosis influences the early period of the healing after distraction osteogenesis in a rat osteoporotic model. J Craniomaxillofac Surg (2010) 0.79
The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies. Leuk Res (2002) 0.79
Fracture associated with hydrogen absorption of sustained tensile-loaded titanium in acid and neutral fluoride solutions. J Biomed Mater Res A (2004) 0.79
Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line. Oral Oncol (2004) 0.79
Two-stage distraction osteogenesis for mandibular segmental defect. J Oral Maxillofac Surg (2004) 0.79
Two rare MPL gene mutations in patients with essential thrombocythemia. Int J Hematol (2009) 0.79
Three-dimensional sodium chloride (NaCl) model for simulated mandibular reconstruction surgery: a new environmentally friendly material. J Med Invest (2014) 0.79
Effects of neutral sodium hydrogen phosphate on the setting property and hemostatic ability of hydroxyapatite putty as a local hemostatic agent for bone. J Biomed Mater Res B Appl Biomater (2004) 0.78
Surface-layer modification of hydroxyapatite ceramic with acid and heat treatments. Dent Mater J (2002) 0.78
Enhancement of apoptosis in salivary gland cancer cells by the combination of oral fluoropyrimidine anticancer agent (S-1) and radiation. Int J Oncol (2004) 0.78
Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study. Int J Hematol (2013) 0.78
A novel monoclonal antibody identified hepatic stem-like cells in rats. Med Mol Morphol (2011) 0.77
Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study. Cancer Sci (2011) 0.77
Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells. Int J Oncol (2012) 0.77
The role of metabotropic glutamate receptor 5 on the stromal cell-derived factor-1/CXCR4 system in oral cancer. PLoS One (2013) 0.77
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes. Leuk Lymphoma (2009) 0.77
Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan. AIDS (2013) 0.77
Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma. Leuk Lymphoma (2014) 0.77
Vertical alveolar distraction osteogenesis with complications in a reconstructed mandible. J Oral Implantol (2003) 0.77
Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload. Int J Hematol (2012) 0.76
The in vitro antibiotic release from anti-washout apatite cement using chitosan. J Mater Sci Mater Med (2002) 0.76
Construction of glycosylated myoglobin by reconstitutional method. Chem Commun (Camb) (2006) 0.75
3-dimensional composite scaffolds consisting of apatite-PLGA-atelocollagen for bone tissue engineering. Dent Mater J (2012) 0.75
Effects of a concurrent chemoradiotherapy with S-1 for locally advanced oral cancer. Oncol Lett (2011) 0.75
Cepharanthin, a biscoclaurine alkaloid, prevents destruction of acinar tissues in murine Sjögren's syndrome. J Rheumatol (2006) 0.75
The synergistic effect of BCR signaling inhibitors combined with an HDAC inhibitor on cell death in a mantle cell lymphoma cell line. Apoptosis (2015) 0.75
Strengthening of calcium phosphate cement by compounding calcium carbonate whiskers. Dent Mater J (2005) 0.75
Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432. Oncol Rep (2013) 0.75
[Evaluation of combination chemotherapy with S-1 and docetaxel for patients with oral squamous cell carcinomas]. Gan To Kagaku Ryoho (2007) 0.75
[Treatment of Hodgkin lymphoma]. Nihon Rinsho (2014) 0.75
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Jpn J Clin Oncol (2014) 0.75
Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination. Blood Coagul Fibrinolysis (2014) 0.75
[A phase III study of the efficacy and safety of meropenem in patients with febrile neutropenia]. Jpn J Antibiot (2012) 0.75
[Treatment strategy of Hodgkin lymphoma]. Rinsho Ketsueki (2014) 0.75
Transplantation of rat hepatic stem-like (HSL) cells with collagen matrices. Hepatol Res (2005) 0.75
[Hodgkin lymphoma--ABVD regimen]. Nihon Rinsho (2015) 0.75
[Hodgkin lymphoma]. Nihon Rinsho (2014) 0.75